Corthera
Corthera is engaged in acquiring, developing and commercializing therapies for illnesses in the acute care setting.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD164m (Public information from Dec 2009)
San Carlos California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$2.1m | Series A | ||
$15.0m | Series B | ||
$23.0m | Series C | ||
$120m Valuation: $120m | Acquisition | ||
Total Funding | CAD54.7m |